Brief: Suven Pharmaceuticals Dec-Quarter Consol Net Profit Falls
Feb 6 (Reuters) - Suven Pharmaceuticals Ltd SUVH.NS :
* DEC-QUARTER CONSOL NET PROFIT 1.08 BILLION RUPEES VERSUS
1.60
BILLION RUPEES
* DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 3.54 BILLION
RUPEES
VERSUS 3.92 BILLION RUPEES
Source text for Eikon: ID:nBSEbF3XdQ
Further company coverage: SUVH.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss